See All Slides - tctmd.com

Slides

$TCT-50. Influence of Age on Clinical Outcomes in Patients with NSTEMI Undergoing Treatment with Abciximab plus Unfractionated Heparin vs. Bivalirudin: Analysis of the ISAR...$

Presentation TCT 2012

TCT-50. Influence of Age on Clinical Outcomes in Patients with NSTEMI Undergoing Treatment with Abciximab plus Unfractionated Heparin vs. Bivalirudin: Analysis of the ISAR...

Presenter: Lamin King

October 23, 2012

Presentation TCT 2012

Post-Fellowship Skill Training: Proctoring and Beyond

Presenter: Paul Sorajja

October 23, 2012

Presentation TCT 2012

Background Medical and Device Therapies for Patients with VADs

Presenter: Emma Birks

October 23, 2012

Presentation TCT 2012

ACP Tips and Tricks

Presenter: David Muller

October 23, 2012

Presentation TCT 2012

ELM Presentation(8)

Presenter: Paul Sorajja

October 23, 2012

Presentation TCT 2012

ROADMAP

Presenter: John O'Connell

October 23, 2012

Presentation TCT 2012

TCT-19. Fractional Flow Reserved Derived from Computed Tomographic Angiography (FFRCT) for Intermediate Severity Coronary Lesions: Results from the DeFACTO Trial...

Presenter: James Min

October 23, 2012

Presentation TCT 2012

Therapies Based on ApoA1 and ApoA1 Milano: Overview of the Field

Presenter: Bryan Brewster

October 23, 2012

Presentation TCT 2012

Protagonist

Presenter: Manesh Patel

October 23, 2012

Presentation TCT 2012

When Do I Prefer PCI for MVD? The Surgeon's Perspective

Presenter: A. Pieter Kappetein

October 23, 2012

Advertisement

Slides

TCT-50. Influence of Age on Clinical Outcomes in Patients with NSTEMI Undergoing Treatment with Abciximab plus Unfractionated Heparin vs. Bivalirudin: Analysis of the ISAR...

Post-Fellowship Skill Training: Proctoring and Beyond

Background Medical and Device Therapies for Patients with VADs

ACP Tips and Tricks

ELM Presentation(8)

ROADMAP

TCT-19. Fractional Flow Reserved Derived from Computed Tomographic Angiography (FFRCT) for Intermediate Severity Coronary Lesions: Results from the DeFACTO Trial...

Therapies Based on ApoA1 and ApoA1 Milano: Overview of the Field

Protagonist

When Do I Prefer PCI for MVD? The Surgeon's Perspective

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content